Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Merck
MRK
|
+$921M |
| 2 |
Union Pacific
UNP
|
+$581M |
| 3 |
Salesforce
CRM
|
+$417M |
| 4 |
Edwards Lifesciences
EW
|
+$409M |
| 5 |
ServiceNow
NOW
|
+$316M |
Top Sells
| 1 |
Caterpillar
CAT
|
+$664M |
| 2 |
RHT
Red Hat Inc
RHT
|
+$632M |
| 3 |
Texas Instruments
TXN
|
+$571M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$540M |
| 5 |
Parker-Hannifin
PH
|
+$513M |
Sector Composition
| 1 | Technology | 21.1% |
| 2 | Healthcare | 17.5% |
| 3 | Consumer Discretionary | 17.06% |
| 4 | Financials | 12.7% |
| 5 | Communication Services | 11.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
Cardlytics
CDLX
$49.8M
| $13.7M | 0.02% |
1,264,354
+465,855
| +58% | +$5.05M |
|
|
BRKL
402
DELISTED
Brookline Bancorp
BRKL
| $13.6M | 0.02% |
985,206
-917,737
| -48% | -$12.7M |
|
|
ABMD
403
DELISTED
Abiomed Inc
ABMD
| $13.5M | 0.02% |
41,543
+861
| +2% | +$280K |
|
|
CBIO
404
Crescent Biopharma, Inc. Common Stock
CBIO
$170M
| $13.5M | 0.02% |
14,221
-767
| -5% | -$726K |
|
405
Travere Therapeutics
TVTX
$2.43B
| $13.4M | 0.01% |
590,504
-203,815
| -26% | -$4.61M |
|
406
Arcosa
ACA
$4.72B
| $13.2M | 0.01% |
+477,878
| New | +$13.2M |
|
407
Dorman Products
DORM
$4.86B
| $13.1M | 0.01% |
145,376
+801
| +0.6% | +$72.1K |
|
|
MRNS
408
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $13.1M | 0.01% |
1,138,690
+663,059
| +139% | +$7.61M |
|
409
Equinor
EQNR
$62.9B
| $12.6M | 0.01% |
+593,845
| New | +$12.6M |
|
|
PXD
410
DELISTED
Pioneer Natural Resource Co.
PXD
| $12.6M | 0.01% |
95,572
-4,402
| -4% | -$579K |
|
411
MPLX
MPLX
$50.8B
| $12.4M | 0.01% |
409,097
-19,167
| -4% | -$581K |
|
412
Spotify
SPOT
$145B
| $12.2M | 0.01% |
107,894
-6,157
| -5% | -$699K |
|
413
Keurig Dr Pepper
KDP
$37.3B
| $12.1M | 0.01% |
471,865
+61,009
| +15% | +$1.56M |
|
|
KA
414
DELISTED
Kineta, Inc. Common Stock
KA
| $12.1M | 0.01% |
26,669
+311
| +1% | +$141K |
|
415
iRhythm Technologies
IRTC
$5.85B
| $11.8M | 0.01% |
170,045
+55,594
| +49% | +$3.86M |
|
416
Halliburton
HAL
$19.3B
| $11.8M | 0.01% |
442,473
-1,615,645
| -79% | -$42.9M |
|
|
AM
417
DELISTED
ANTERO MIDSTREAM PARTNERS LP
AM
| $11.7M | 0.01% |
544,718
+91,638
| +20% | +$1.96M |
|
|
EPZM
418
DELISTED
Epizyme, Inc
EPZM
| $11.6M | 0.01% |
1,876,995
-324,042
| -15% | -$2M |
|
419
Heritage Financial
HFWA
$842M
| $11.5M | 0.01% |
388,572
+147,795
| +61% | +$4.39M |
|
|
OLBK
420
DELISTED
Old Line Bancshares, Inc.
OLBK
| $11.5M | 0.01% |
438,758
+4,485
| +1% | +$118K |
|
421
American Express
AXP
$225B
| $11.4M | 0.01% |
+119,535
| New | +$11.4M |
|
422
ManpowerGroup
MAN
$1.75B
| $11.4M | 0.01% |
175,539
-99,772
| -36% | -$6.47M |
|
|
ENLK
423
DELISTED
EnLink Midstream Partners, LP
ENLK
| $11.4M | 0.01% |
1,031,557
-48,333
| -4% | -$532K |
|
|
NUVA
424
DELISTED
NuVasive, Inc.
NUVA
| $11.3M | 0.01% |
227,230
+3,991
| +2% | +$198K |
|
425
Repligen
RGEN
$6.76B
| $11.1M | 0.01% |
211,057
+2,367
| +1% | +$125K |
|